Synthesis and Antimycobacterial Activity of Novel Amino Alcohols Containing Central Core of the Anti‐HIV Drugs Lopinavir and Ritonavir
- 20 September 2011
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 78 (6) , 1031-1034
Abstract
Eleven new amino alcohol derivatives have been synthesized from reactions of lopinavir intermediate and heteroaromatic aldehyde in good yields. These compounds, the antiretrovirals (lopinavir and ritonavir) and lopinavir key intermediate were evaluated as antibacterial agents against Mycobacterium tuberculosis H37Rv using the Alamar Blue susceptibility test and their activity expressed as the minimum inhibitory concentration (MIC) in μm. Ten amino alcohols evaluated displayed significant activity (MIC between 6.15 and 108.4 μm) when compared to first‐line drug ethambutol (MIC = 15.9 μm). Three of them showed more activity than ethambutol (MIC = 6.15; 6.21 and 13.4 μm). The appreciable activity of these compounds can be considered an important finding for the rational design of new leads for anti‐TB compounds.Keywords
This publication has 22 references indexed in Scilit:
- Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, Part 2European Journal of Medicinal Chemistry, 2009
- Synthesis and antimalarial activity of hydroxyethylpiperazine derivativesEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and anti-mycobacterial activity of (E)-N′-(monosubstituted-benzylidene)isonicotinohydrazide derivativesEuropean Journal of Medicinal Chemistry, 2008
- Design, synthesis, and evaluation of novel ethambutol analoguesBioorganic & Medicinal Chemistry Letters, 2008
- Fármacos no combate à tuberculose: passado, presente e futuroQuímica Nova, 2005
- Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease InhibitorsAntimicrobial Agents and Chemotherapy, 2005
- Antileishmanial activity of HIV protease inhibitorsInternational Journal of Antimicrobial Agents, 2005
- Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolatesDiagnostic Microbiology and Infectious Disease, 2004
- Comparison of Flow Cytometric and Alamar Blue Tests with the Proportional Method for Testing Susceptibility of Mycobacterium tuberculosis to Rifampin and IsoniazidJournal of Clinical Microbiology, 2004
- Syntheses of FDA Approved HIV Protease InhibitorsSynthesis, 2001